Compare AVGO & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVGO | BSX |
|---|---|---|
| Founded | 1961 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8T | 137.8B |
| IPO Year | 2009 | 1992 |
| Metric | AVGO | BSX |
|---|---|---|
| Price | $332.66 | $91.04 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 27 | 18 |
| Target Price | ★ $423.19 | $124.44 |
| AVG Volume (30 Days) | ★ 31.2M | 9.3M |
| Earning Date | 03-05-2026 | 02-04-2026 |
| Dividend Yield | ★ 0.74% | N/A |
| EPS Growth | ★ 286.90 | 54.68 |
| EPS | ★ 4.77 | 1.87 |
| Revenue | ★ $63,887,000,000.00 | $19,349,000,000.00 |
| Revenue This Year | $54.71 | $21.05 |
| Revenue Next Year | $36.41 | $11.44 |
| P/E Ratio | $73.73 | ★ $47.10 |
| Revenue Growth | ★ 23.87 | 21.61 |
| 52 Week Low | $138.10 | $85.98 |
| 52 Week High | $414.61 | $109.50 |
| Indicator | AVGO | BSX |
|---|---|---|
| Relative Strength Index (RSI) | 41.60 | 38.86 |
| Support Level | $334.42 | $87.22 |
| Resistance Level | $354.51 | $100.90 |
| Average True Range (ATR) | 11.62 | 2.15 |
| MACD | 0.14 | -0.67 |
| Stochastic Oscillator | 6.73 | 29.88 |
Broadcom is one of the largest semiconductor companies in the world and has also expanded into infrastructure software. Its semiconductors primarily serve computing, wired connectivity, and wireless connectivity. It is primarily a fabless designer but holds some manufacturing in-house, such as for its best-of-breed film bulk acoustic resonator filters that sell into the Apple iPhone. In software, it sells virtualization, infrastructure, and security software to large enterprises, financial institutions, and governments. Broadcom is the product of consolidation. Its businesses are an amalgamation of former companies like legacy Broadcom and Avago Technologies in chips, as well as VMware, Brocade, CA Technologies, and Symantec in software.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.